Literature DB >> 25739468

Biophysical characterization of naturally occurring titin M10 mutations.

Michael W Rudloff1, Alec N Woosley1, Nathan T Wright1.   

Abstract

The giant proteins titin and obscurin are important for sarcomeric organization, stretch response, and sarcomerogenesis in myofibrils. The extreme C-terminus of titin (the M10 domain) binds to the N-terminus of obscurin (the Ig1 domain) in the M-band. The high-resolution structure of human M10 has been solved, along with M10 bound to one of its two known molecular targets, the Ig1 domain of obscurin-like. Multiple M10 mutations are linked to limb-girdle muscular dystrophy type 2J (LGMD2J) and tibial muscular dystrophy (TMD). The effect of the M10 mutations on protein structure and function has not been thoroughly characterized. We have engineered all four of the naturally occurring human M10 missense mutants and biophysically characterized them in vitro. Two of the four mutated constructs are severely misfolded, and cannot bind to the obscurin Ig1 domain. One mutation, H66P, is folded at room temperature but unfolds at 37°C, rendering it binding incompetent. The I57N mutation shows no significant structural, dynamic, or binding differences from the wild-type domain. We suggest that this mutation is not directly responsible for muscle wasting disease, but is instead merely a silent mutation found in symptomatic patients. Understanding the biophysical basis of muscle wasting disease can help streamline potential future treatments.
© 2015 The Protein Society.

Entities:  

Keywords:  LGMD2J; M10; NMR; TMD; obscurin; titin; titinopathy

Mesh:

Substances:

Year:  2015        PMID: 25739468      PMCID: PMC4456108          DOI: 10.1002/pro.2670

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  48 in total

1.  Changes in the cross-striations of muscle during contraction and stretch and their structural interpretation.

Authors:  H HUXLEY; J HANSON
Journal:  Nature       Date:  1954-05-22       Impact factor: 49.962

2.  The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy.

Authors:  Nathan T Wright; Kristen M Varney; Karen C Ellis; Joseph Markowitz; Rossitza K Gitti; Danna B Zimmer; David J Weber
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

3.  Monitoring protein aggregation during thermal unfolding in circular dichroism experiments.

Authors:  Sangeeta Benjwal; Shikha Verma; Klaus-Heinrich Röhm; Olga Gursky
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

4.  The effects of buffers and pH on the thermal stability, unfolding and substrate binding of RecA.

Authors:  Michael A Metrick; Joshua E Temple; Gina MacDonald
Journal:  Biophys Chem       Date:  2013-08-16       Impact factor: 2.352

5.  Error estimation and global fitting in transverse-relaxation dispersion experiments to determine chemical-exchange parameters.

Authors:  Rieko Ishima; Dennis A Torchia
Journal:  J Biomol NMR       Date:  2005-05       Impact factor: 2.835

Review 6.  Recombinant protein folding and misfolding in Escherichia coli.

Authors:  François Baneyx; Mirna Mujacic
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

7.  Mapping the binding site on small ankyrin 1 for obscurin.

Authors:  Maegen A Borzok; Dawn H Catino; James D Nicholson; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch
Journal:  J Biol Chem       Date:  2007-08-25       Impact factor: 5.157

Review 8.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

9.  The kinase domain of titin controls muscle gene expression and protein turnover.

Authors:  Stephan Lange; Fengqing Xiang; Andrey Yakovenko; Anna Vihola; Peter Hackman; Elena Rostkova; Jakob Kristensen; Birgit Brandmeier; Gereon Franzen; Birgitta Hedberg; Lars Gunnar Gunnarsson; Simon M Hughes; Sylvie Marchand; Thomas Sejersen; Isabelle Richard; Lars Edström; Elisabeth Ehler; Bjarne Udd; Mathias Gautel
Journal:  Science       Date:  2005-03-31       Impact factor: 47.728

10.  C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.

Authors:  Virginie Carmignac; Mustafa A M Salih; Susana Quijano-Roy; Sylvie Marchand; Molham M Al Rayess; Maowia M Mukhtar; Jon A Urtizberea; Siegfried Labeit; Pascale Guicheney; France Leturcq; Mathias Gautel; Michel Fardeau; Kevin P Campbell; Isabelle Richard; Brigitte Estournet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

View more
  9 in total

1.  Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.

Authors:  Ronald Ng; Heather Manring; Nikolaos Papoutsidakis; Taylor Albertelli; Nicole Tsai; Claudia J See; Xia Li; Jinkyu Park; Tyler L Stevens; Prameela J Bobbili; Muhammad Riaz; Yongming Ren; Christopher E Stoddard; Paul Ml Janssen; T Jared Bunch; Stephen P Hall; Ying-Chun Lo; Daniel L Jacoby; Yibing Qyang; Nathan Wright; Maegen A Ackermann; Stuart G Campbell
Journal:  JCI Insight       Date:  2019-06-13

2.  Obscurin is a semi-flexible molecule in solution.

Authors:  Jacob A Whitley; Aidan M Ex-Willey; Daniel R Marzolf; Maegen A Ackermann; Anthony L Tongen; Oleksandr Kokhan; Nathan T Wright
Journal:  Protein Sci       Date:  2019-02-06       Impact factor: 6.725

3.  When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability.

Authors:  Atsushi Fukuzawa; Daniel Koch; Sarah Grover; Martin Rees; Mathias Gautel
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

Review 4.  Increasing Role of Titin Mutations in Neuromuscular Disorders.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Bjarne Udd; Peter Hackman
Journal:  J Neuromuscul Dis       Date:  2016-08-30

5.  Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Peter A Hecker; Benjamin L Prosser; Brendan King; Kelly A O'Connell; Alyssa Grogan; Logan C Meyer; Christopher E Berndsen; Nathan T Wright; W Jonathan Lederer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Sci Adv       Date:  2017-06-07       Impact factor: 14.136

6.  Structural diversity in the atomic resolution 3D fingerprint of the titin M-band segment.

Authors:  Spyros D Chatziefthimiou; Philipp Hornburg; Florian Sauer; Simone Mueller; Deniz Ugurlar; Emma-Ruoqi Xu; Matthias Wilmanns
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

7.  Making sense of missense variants in TTN-related congenital myopathies.

Authors:  Heinz Jungbluth; Mathias Gautel; Martin Rees; Roksana Nikoopour; Atsushi Fukuzawa; Ay Lin Kho; Miguel A Fernandez-Garcia; Elizabeth Wraige; Istvan Bodi; Charu Deshpande; Özkan Özdemir; Hülya-Sevcan Daimagüler; Mark Pfuhl; Mark Holt; Birgit Brandmeier; Sarah Grover; Joël Fluss; Cheryl Longman; Maria Elena Farrugia; Emma Matthews; Michael Hanna; Francesco Muntoni; Anna Sarkozy; Rahul Phadke; Ros Quinlivan; Emily C Oates; Rolf Schröder; Christian Thiel; Jens Reimann; Nicol Voermans; Corrie Erasmus; Erik-Jan Kamsteeg; Chaminda Konersman; Carla Grosmann; Shane McKee; Sandya Tirupathi; Steven A Moore; Ekkehard Wilichowski; Elke Hobbiebrunken; Gabriele Dekomien; Isabelle Richard; Peter Van den Bergh; Cristina Domínguez-González; Sebahattin Cirak; Ana Ferreiro
Journal:  Acta Neuropathol       Date:  2021-01-15       Impact factor: 17.088

8.  TITINdb-a computational tool to assess titin's role as a disease gene.

Authors:  Anna Laddach; Mathias Gautel; Franca Fraternali
Journal:  Bioinformatics       Date:  2017-11-01       Impact factor: 6.937

9.  A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.

Authors:  Daniela Rossi; Johanna Palmio; Anni Evilä; Lucia Galli; Virginia Barone; Tracy A Caldwell; Rachel A Policke; Esraa Aldkheil; Christopher E Berndsen; Nathan T Wright; Edoardo Malfatti; Guy Brochier; Enrico Pierantozzi; Albena Jordanova; Velina Guergueltcheva; Norma Beatriz Romero; Peter Hackman; Bruno Eymard; Bjarne Udd; Vincenzo Sorrentino
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.